Sarclisa (isatuximab)

pCPA File Number: 21752

Negotiation Status:

Concluded with an LOI

Indication(s):

In combination with carfilzomib and dexamethasone, for the treatment of adult patients with relapsed or refractory multiple myeloma who have received 1 to 3 prior lines of therapy

Sponsor/Manufacturer:

Sanofi Genzyme

CADTH Project Number:

PC0256

pCPA Engagement Letter Issued:

2022-05-13

Negotiation Process Concluded:

2023-03-07